Skip to content

TARIFICA SOINS

Active
Private limited companyfounded 2009active for 17 yearsChaussée de Mons 316, 6150 Anderlues, BelgiumKBO/BCE: BE 0812.101.420
Summary

TARIFICA SOINS has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.9m and a net result of €780,154. Equity is growing by about 13% per year across the filed financial years. The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Nursing and midwifery
NACE 86940Office administrative and support services NACE 82100
#2 company by total assets in Anderlues, Health and social work sector1 site
Size
€29.5mturnover 2025
Staff
6.5 FTE
Equity
€1.9m
Profit
€780,154
Financial health
93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Parent
BINCHE SOINS · 100%
Accounts 120 days early0 of 7 deeds read
Why 93lowers riskLiquidity: current ratio 9.28, cash €1.4mSector: Human health activities (NACE 86)Profit of €780,154 (financial year 2025)Figures for financial year 2025 (filed 09-04-2026)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 44% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 65+4
equity 40.2% of total assets
Liquidity 86-3
short-term debt 10.3% · cash 28.7%
Profitability 71-7
return on assets 16.2%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,011 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1%highest value 12-2024: < 0.1%● unchanged vs 11-2024highest value 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026lowest value 06-2026: < 0.1%● unchanged vs 05-2026lowest value 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €170,000 on 30-day terms is acceptable
Liquidity ample (current ratio 9.28, compared with 12.27 in 2024; short-term debt: 10.3% and cash: 28.7% of total assets), but 59.8% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 33% on solvency, 69% on liquidity, 15% on profitability and 58% on growth.

The bankruptcy probability was computed on 08-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk○neutral
lowers risk · Liquidity: current ratio 9.28, cash €1.4m
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Profit of €780,154 (financial year 2025)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 09-04-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-04-2026, 120 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
120 days early
2024
72 days early
2023
36 days early
2022
4 days early
2021
58 days late
2020
16 days early
2019
28 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 23 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 June (4 of the last 5 filed years within 85 days of that day).
Companies Code · seven months
Where today falls in the filing period
09-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · unclassified…
  2. Annual accounts filedfinancial year 2024 · unclassified…
  3. Highest result from 2018 to 2025net €951,543 ▲101%

Key points

  • Positive: Company by total assets in Anderlues, Health and…in the Checked rankings #2 View
  • Positive: 8 profitable years in a rowprofit 2025: €780,154 8 years View
  • Controlled by BINCHE SOINSultimately: UPH 100% View
  • Positive: Equity rose in 2025from €1.5m to €1.9m ▲ 28.6% View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

By topic

Financials

Financial year
2025
Turnover
€29.5m
Profit
€780,154
Solvency
40.2%
Turnover▲ 3.5%
Net result
20232025
Go to Financials

Timeline

Events
19
Since
2011
Next accounts
by 31-07-2027
  1. 25-06-2024Annual accounts filed
  2. 27-07-2023Annual accounts filed
  3. 27-09-2022Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Nursing and midwiferyNACE 86940
Founded
05-06-2009
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.